Back to MetLife Investment Management, LLC MetLife Investment Management, LLC

KNSAKNSA

Showing 0 of 2 quarters

Position history for MetLife Investment Management, LLCMetLife Investment Management, LLC's holdings in Kiniksa Pharmaceuticals International, plc

No. MetLife Investment Management exited its KNSA (Kiniksa Pharmaceuticals International) position in Q4 2023. Its Q3 2023 13F listed 17,349 shares worth $301,352. MetLife Investment Management first reported KNSA in Q3 2023 and held it in 1 quarterly 13F filing.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used